Skip to content
healthcare.dev

Tucks Triple Relief Hemorrhoidal

NDC 10157-2126, WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, and PHENYLEPHRINE HYDROCHLORIDE, cream, from Blistex Inc..

Product NDC
10157-2126
Status
Listed
Labeler
Blistex Inc.
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M015
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10157-2126 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • WHITE PETROLATUM16 g/100g
  • GLYCERIN15 g/100g
  • PRAMOXINE HYDROCHLORIDE1 g/100g
  • PHENYLEPHRINE HYDROCHLORIDE.25 g/100g

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Allergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
10157-2126-1101572126011 TUBE, WITH APPLICATOR in 1 CARTON (10157-2126-1) / 26 g in 1 TUBE, WITH APPLICATOR

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 10157-2126 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10157-2126 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10157-2126. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.